Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Behavioral Neurology Topic Center

News
FDA Advisory Committee Recommends Approval of Adrenoleukodystrophy Treatment
07/01/2022
Jolynn Tumolo
An FDA advisory panel unanimously recommended the approval of the investigational gene therapy elivaldogene autotemcel (eli-cel) for the treatment of early active cerebral adrenoleukodystrophy in pediatric patients.
An FDA advisory panel unanimously recommended the approval of the investigational gene therapy elivaldogene autotemcel (eli-cel) for the treatment of early active cerebral adrenoleukodystrophy in pediatric patients.
An FDA advisory panel...
07/01/2022
Neurology
News
Pandemic Babies Scored Lower on Neurodevelopmental Screeners Than Their Predecessors
06/28/2022
Jolynn Tumolo
Birth during the COVID-19 pandemic, but not in utero exposure to maternal SARS-CoV-2 infection, is associated with lower scores on several neurodevelopment screener subdomains at age 6 months.
Birth during the COVID-19 pandemic, but not in utero exposure to maternal SARS-CoV-2 infection, is associated with lower scores on several neurodevelopment screener subdomains at age 6 months.
Birth during the COVID-19...
06/28/2022
Neurology
Pop quiz.
Quiz
Is topiramate a safe alternative to valporate when prescribing antiseizure medication to pregnant women?
06/09/2022
Take the quiz now to test your knowledge!
Take the quiz now to test your knowledge!
Take the quiz now to test your...
06/09/2022
Neurology
News
Prenatal Exposure to Antiseizure Medications May Increase Risk of Autism and Intellectual Disability
06/07/2022
Brionna Mendoza
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure...
06/07/2022
Neurology
News
Mortality Risk Higher With ASD, ADHD
04/05/2022
Jolynn Tumolo
ASD and ADHD are associated with a significantly increased risk of all-cause mortality, suggests a systematic review and meta-analysis published in JAMA Pediatrics.
ASD and ADHD are associated with a significantly increased risk of all-cause mortality, suggests a systematic review and meta-analysis published in JAMA Pediatrics.
ASD and ADHD are associated with...
04/05/2022
Psych Congress Network
News
Deep Learning Algorithm Identifies Differences in Brains of Boys and Girls with Autism
03/15/2022
Jolynn Tumolo
Functional brain organization differs between boys with autism and girls with autism, according to a deep learning study out of the Stanford University School of Medicine in California.
Functional brain organization differs between boys with autism and girls with autism, according to a deep learning study out of the Stanford University School of Medicine in California.
Functional brain organization...
03/15/2022
Psych Congress Network
News
ECNP Virtual Congress Roundup: Data Mining Method Detects Psychosis Risk Early; Electroconvulsive Therapy Cuts Suicide Risk by 84% in Bipolar Disorder; and More
09/14/2020
This roundup discusses a variety of new findings presented at the 33rd European College of Neuropsychopharmacology Congress (Virtual).
This roundup discusses a variety of new findings presented at the 33rd European College of Neuropsychopharmacology Congress (Virtual).
This roundup discusses a variety...
09/14/2020
Neurology
News
Playing Contact Sports in Youth Is Not Linked With MCI, Depression Later
10/21/2019
Researchers determined the association between these symptoms in young adulthood and contact sport participation in adolescence, by evaluating the cognition and depressive symptoms of more than 10,900 participants.
Researchers determined the association between these symptoms in young adulthood and contact sport participation in adolescence, by evaluating the cognition and depressive symptoms of more than 10,900 participants.
Researchers determined the...
10/21/2019
Neurology
Quiz
Pop Quiz: RLS and Concomitant Anxiety
10/20/2019
Concomitant anxiety is common among patients with restless legs syndrome (RLS). Based on the AAN’s guideline on RLS treatment in adults, which medication is recommended for patients with RLS and concomitant anxiety?
Concomitant anxiety is common among patients with restless legs syndrome (RLS). Based on the AAN’s guideline on RLS treatment in adults, which medication is recommended for patients with RLS and concomitant anxiety?
Concomitant anxiety is common...
10/20/2019
Neurology
Podcasts
Using the GAD-2 for Screening Anxiety in Patients With MS
11/06/2018
Dr Abbey Hughes from Johns Hopkins University School of Medicine talks about her research on anxiety screening in patients with multiple sclerosis.
Dr Abbey Hughes from Johns Hopkins University School of Medicine talks about her research on anxiety screening in patients with multiple sclerosis.
Dr Abbey Hughes from Johns...
11/06/2018
Neurology

Advertisement

Advertisement

News

Young woman sleeping
News
Adolescents With Higher Adiposity More Vulnerable to Cognitive Impairments From Poor Sleep
06/13/2024
Meagan Thistle
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Adolescents with higher levels...
06/13/2024
Neurology
Illustration of the brain
News
Hippocampus May Be Epicenter of Psychosis Brain Changes
09/27/2023
Jolynn Tumolo
Gray matter changes that occur across different stages of psychosis may begin in the hippocampus, suggest study results published in JAMA Psychiatry.
Gray matter changes that occur across different stages of psychosis may begin in the hippocampus, suggest study results published in JAMA Psychiatry.
Gray matter changes that occur...
09/27/2023
Neurology
Image of man with neurological issue
News
Anxiety Alters Neural Pathways for Emotional Control, Highlighting Compensatory Mechanisms
08/29/2023
Anxious individuals rely less on the dorsolateral prefrontal cortex (FPl) for controlling emotional actions, according to a recent study published in Nature Communications.
Anxious individuals rely less on the dorsolateral prefrontal cortex (FPl) for controlling emotional actions, according to a recent study published in Nature Communications.
Anxious individuals rely less on...
08/29/2023
Psych Congress Network
News
Autism Spectrum Disorder Prevalence Rises Among Minority Children, CDC Report Finds
04/14/2023
Meagan Thistle
The rate of children diagnosed with autism spectrum disorder (ASD) continues to increase, particularly in non-white children, a CDC surveillance summary finds.
The rate of children diagnosed with autism spectrum disorder (ASD) continues to increase, particularly in non-white children, a CDC surveillance summary finds.
The rate of children diagnosed...
04/14/2023
Psych Congress Network
News
Anxiety, Depression, Neural Interruption More Likely in Adolescents Subjected to Corporal Punishment
11/30/2022
Brionna Mendoza
A. new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging demonstrates that physical punishment disrupts brain activity and neurodevelopment.
A. new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging demonstrates that physical punishment disrupts brain activity and neurodevelopment.
A. new study published in...
11/30/2022
Psych Congress Network
News
Depression Treatment Changes Brain Structure in 6 Weeks
10/31/2022
Jolynn Tumolo
Adults with MDD showed increased brain connectivity after about 6 weeks of inpatient depression treatment.
Adults with MDD showed increased brain connectivity after about 6 weeks of inpatient depression treatment.
Adults with MDD showed increased...
10/31/2022
Psych Congress Network
News
72 Genes With Very Strong Autism Associations Identified in Large-Scale Analysis
09/07/2022
Jolynn Tumolo
A genetic analysis of more than 150,000 people has identified 72 genes very strongly associated with autism and more than 250 others with strong autism associations. Researchers published their findings online ahead of print in Nature...
A genetic analysis of more than 150,000 people has identified 72 genes very strongly associated with autism and more than 250 others with strong autism associations. Researchers published their findings online ahead of print in Nature...
A genetic analysis of more than...
09/07/2022
Neurology
News
Balovaptan Fails to Improve Social Communication in Autism Spectrum Disorder
07/19/2022
Jolynn Tumolo
Oral balovaptan did not demonstrate efficacy in improving socialization and communication in a randomized clinical trial of children and adolescents with autism spectrum disorder.
Oral balovaptan did not demonstrate efficacy in improving socialization and communication in a randomized clinical trial of children and adolescents with autism spectrum disorder.
Oral balovaptan did not...
07/19/2022
Psych Congress Network
News
FDA Advisory Committee Recommends Approval of Adrenoleukodystrophy Treatment
07/01/2022
Jolynn Tumolo
An FDA advisory panel unanimously recommended the approval of the investigational gene therapy elivaldogene autotemcel (eli-cel) for the treatment of early active cerebral adrenoleukodystrophy in pediatric patients.
An FDA advisory panel unanimously recommended the approval of the investigational gene therapy elivaldogene autotemcel (eli-cel) for the treatment of early active cerebral adrenoleukodystrophy in pediatric patients.
An FDA advisory panel...
07/01/2022
Neurology
News
Pandemic Babies Scored Lower on Neurodevelopmental Screeners Than Their Predecessors
06/28/2022
Jolynn Tumolo
Birth during the COVID-19 pandemic, but not in utero exposure to maternal SARS-CoV-2 infection, is associated with lower scores on several neurodevelopment screener subdomains at age 6 months.
Birth during the COVID-19 pandemic, but not in utero exposure to maternal SARS-CoV-2 infection, is associated with lower scores on several neurodevelopment screener subdomains at age 6 months.
Birth during the COVID-19...
06/28/2022
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement